NADDI lauds real-time, drug stop-sale system in North Carolina

NewsGuard 100/100 Score

The National Association of Drug Diversion Investigators (NADDI) – a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion – today lauded the latest results achieved by the real-time, stop-sale system in North Carolina.  Data for 2012 released by the National Precursor Log Exchange (NPLEx) shows that so far this year, electronic technology in the Tar Heel State blocked the sale of more than 41,000 boxes of medicine containing pseudoephedrine (PSE), preventing more than 91,000 grams from potentially being diverted by meth criminals.  NPLEx was fully implemented in North Carolina in January 2012.

"North Carolina's brand new real-time, stop-sale technology is helping police officers and retailers make serious progress against meth production," said Charles F. Cichon, executive director of the National Association of Drug Diversion Investigators (NADDI).  "Retailers have blocked thousands of unlawful attempted sales each month, and law enforcement officials are using information collected by the system to make arrests.  The technology also benefits responsible consumers who are able to purchase the cold and allergy medicines they need for relief from common cold and seasonal allergy symptoms.  Going forward, it's important for North Carolina leaders to give the new technology time to work as it is clearly demonstrating it already is."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Milk ladder approach offers hope for children with cow's milk allergy